Advertisement

Topics

Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV

01:00 EDT 8 May 2018 | Labiotech.eu

TC Biopharm has partnered with Scotia Biologics to produce tumor-specific antibodies for a new generation of safer CAR-T therapies against multiple types of tumors as well as viral infections such as HIV. The Scottish biotech TC Biopharm will be working ...

This awesome article Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV

NEXT ARTICLE

More From BioPortfolio on "Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...